We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Teladoc (TDOC) Unveils App to Simplify Whole-Person Care
Read MoreHide Full Article
Teladoc Health, Inc. (TDOC - Free Report) recently introduced a comprehensive digital app that promises to offer personalized care and cater to the whole-person healthcare needs of individuals. The benefits of the app can be availed by selected clients from January, which will be further extended across the market by late 2023.
The newly unveiled solution paves way for consumers to access the extensive services suite of Teladoc Health comprising primary care, mental health and chronic condition management services from a single platform.
The app works by digital integration of comprehensive healthcare services within a 24/7 engagement platform, which in turn, converts real-time data from clinicians and patients into applied health signals.
Consumers can seamlessly steer eligible services across the app and subsequently, evaluate diversified physician-based integrated care plans that would address their physical, mental and socioeconomic needs.
It is also worth mentioning that the app will offer the extensive services suite of Teladoc Health in both English and Spanish language. The decision to make the services available in Spanish is a well-timed move on TDOC’s part, considering the sizable Spanish-speaking population in the United States.
The latest app launch reinforces Teladoc Health’s sincere efforts to make use of clinical and digital solutions that perfectly align with market needs for providing whole-person care. The demand for virtual care, which witnessed a surge with the COVID outbreak, shows no signs of slowing down. According to a TDOC study, 60% of consumers choose virtual care as consumers become weary of ineffective care coordination.
Teladoc Health has a robust telehealth platform in place for addressing the strong demand for virtual care. The platform was built through advanced technologies, partnerships with well-established healthcare providers and substantial investments. It also continues to launch whole-person virtual care solutions integrated with lucrative features from time to time.
Last year, Teladoc Health introduced an innovative chronic condition management solution named Chronic Care Complete to offer whole-person care to individuals grappling with multiple chronic conditions.
Shares of Teladoc Health have lost 42.2% in the past six months compared with the industry’s 10.1% decline.
STAAR Surgical’s earnings surpassed estimates in each of the last four quarters, the average being 61.05%. The Zacks Consensus Estimate for STAA’s 2023 earnings indicates a 16.9% rise, while the same for revenues suggests an improvement of 24.5% from the respective prior-year estimates. The consensus mark for STAA’s 2023 earnings has moved 5.1% north in the past 60 days.
The bottom line of Lantheus outpaced estimates in each of the trailing four quarters, the average being 51.09%. The Zacks Consensus Estimate for LNTH’s 2023 earnings indicates a 10% rise, while the same for revenues suggests an improvement of 11.9% from the respective prior-year estimates. The consensus mark for LNTH’s 2023 earnings has moved 0.2% north in the past 30 days.
Merit Medical Systems’ earnings outpaced estimates in each of the trailing four quarters, the average being 25.35%. The Zacks Consensus Estimate for MMSI’s 2023 earnings indicates a 9.9% rise, while the same for revenues suggests an improvement of 4.8% from the respective prior-year estimates. MMSI has witnessed one upward estimate revision for 2023 earnings compared to no downward revision over the past 60 days.
The Merit Medical Systems stock has gained 29.9% in the past six months. However, shares of STAAR Surgical and Lantheus have lost 26.5% and 22.5%, respectively, in the same time frame.
See More Zacks Research for These Tickers
Pick one free report - opportunity may be withdrawn at any time
Image: Shutterstock
Teladoc (TDOC) Unveils App to Simplify Whole-Person Care
Teladoc Health, Inc. (TDOC - Free Report) recently introduced a comprehensive digital app that promises to offer personalized care and cater to the whole-person healthcare needs of individuals. The benefits of the app can be availed by selected clients from January, which will be further extended across the market by late 2023.
The newly unveiled solution paves way for consumers to access the extensive services suite of Teladoc Health comprising primary care, mental health and chronic condition management services from a single platform.
The app works by digital integration of comprehensive healthcare services within a 24/7 engagement platform, which in turn, converts real-time data from clinicians and patients into applied health signals.
Consumers can seamlessly steer eligible services across the app and subsequently, evaluate diversified physician-based integrated care plans that would address their physical, mental and socioeconomic needs.
It is also worth mentioning that the app will offer the extensive services suite of Teladoc Health in both English and Spanish language. The decision to make the services available in Spanish is a well-timed move on TDOC’s part, considering the sizable Spanish-speaking population in the United States.
The latest app launch reinforces Teladoc Health’s sincere efforts to make use of clinical and digital solutions that perfectly align with market needs for providing whole-person care. The demand for virtual care, which witnessed a surge with the COVID outbreak, shows no signs of slowing down. According to a TDOC study, 60% of consumers choose virtual care as consumers become weary of ineffective care coordination.
Teladoc Health has a robust telehealth platform in place for addressing the strong demand for virtual care. The platform was built through advanced technologies, partnerships with well-established healthcare providers and substantial investments. It also continues to launch whole-person virtual care solutions integrated with lucrative features from time to time.
Last year, Teladoc Health introduced an innovative chronic condition management solution named Chronic Care Complete to offer whole-person care to individuals grappling with multiple chronic conditions.
Shares of Teladoc Health have lost 42.2% in the past six months compared with the industry’s 10.1% decline.
Image Source: Zacks Investment Research
Zacks Rank & Key Picks
TDOC currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Medical space are STAAR Surgical Company (STAA - Free Report) , Lantheus Holdings, Inc. and Merit Medical Systems, Inc. (MMSI - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
STAAR Surgical’s earnings surpassed estimates in each of the last four quarters, the average being 61.05%. The Zacks Consensus Estimate for STAA’s 2023 earnings indicates a 16.9% rise, while the same for revenues suggests an improvement of 24.5% from the respective prior-year estimates. The consensus mark for STAA’s 2023 earnings has moved 5.1% north in the past 60 days.
The bottom line of Lantheus outpaced estimates in each of the trailing four quarters, the average being 51.09%. The Zacks Consensus Estimate for LNTH’s 2023 earnings indicates a 10% rise, while the same for revenues suggests an improvement of 11.9% from the respective prior-year estimates. The consensus mark for LNTH’s 2023 earnings has moved 0.2% north in the past 30 days.
Merit Medical Systems’ earnings outpaced estimates in each of the trailing four quarters, the average being 25.35%. The Zacks Consensus Estimate for MMSI’s 2023 earnings indicates a 9.9% rise, while the same for revenues suggests an improvement of 4.8% from the respective prior-year estimates. MMSI has witnessed one upward estimate revision for 2023 earnings compared to no downward revision over the past 60 days.
The Merit Medical Systems stock has gained 29.9% in the past six months. However, shares of STAAR Surgical and Lantheus have lost 26.5% and 22.5%, respectively, in the same time frame.